EV-associated programmed death-ligand 1 (PD-L1) directly engages PD-1 on T cells and may exert broader and more sustained immunosuppressive effects than tumor cell membrane-bound PD-L1 by enabling distal immune modulation and multivalent inhibitory signaling. The gene discussed is CD274; the disease is neoplasm.